BSECompany Update2d ago · 29 Oct 2026, 05:08 pm

News Paper Publication for Basis of Allotment of Right Issue

Natco Pharma Ltd · 524816

✦ AI SummaryFundraise

Natco Pharma Ltd has published the basis of allotment of its rights issue in newspapers as per SEBI regulations.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

6df11c65-d6d8-4b44-bfb3-b837d594c607.pdf

pdf

Download →
View document text
29th October, 2026 Corporate Relationship Department Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd Mumbai 400 001 Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir / Madam Sub: - Paper Publications Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find enclosed the copies of the newspaper Publications as appeared on 29th October, 2026 on Financial Express , Jana Satta and Surya regarding the Basis of Allotment of the Rights Issue of the Company. The above publications are available on the website of the Company. Thanking you Yours faithfully For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer